Skip to content

REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG)

Validation of REEV SENSE Biomarkers Precision for Gait Analysis in Subjects With Post-stroke Gait Impairment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06234878
Acronym
SENS-AG
Enrollment
23
Registered
2024-01-31
Start date
2024-01-08
Completion date
2025-04-01
Last updated
2025-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait Disorders, Neurologic, Stroke

Keywords

Stroke, Gait analysis, Accelerometer, Gait impairment

Brief summary

The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker to measure gait features in subjects with post-stroke gait impairment. REEV SENSE is intended to be used by trained healthcare professionals as a simple procedure adapted to clinical routine. The reference method for performance comparison will be motion capture.

Detailed description

REEV SENSE is a medical device, with pending FDA and CE certifications in class 1. It is a connected gait tracker set primarily on the leg or foot, and eventually on lower limb locations. It contains an accelerometer, a certified standard battery and motion analysis algorithms that will rapidly compute easy-to-use walking analyses accessible to healthcare professionals on a mobile app. Standard gait biomarkers such as velocity, stride length, or stance and swing times will be computed. However, REEV has also developed a new biomarker, the knee position predictor (KPP), which will provide a more accurate quantification of each individual gait profile. The present REEV SENSE study is the first to test subjects with a pathological context, i.e. with post-stroke ambulation deficit. Performance of REEV SENSE has already been established in healthy volunteers in comparison to the reference motion capture system, indicating good technical and metrological performance. The study will take place at the MIT Center for Clinical and Translational Research (CCTR), a reference center with a fully equipped gait lab. Each participating volunteer will be equipped with REEV SENSE and the reference motion capture system. The participant will be asked to walk at a comfortable self selected pace for about 15 minutes back and forth along a 10m walkway. He or she may rest at any time during the walking session. REEV SENSE and motion capture data will be recorded automatically and simultaneously during the same walking session.

Interventions

DEVICEREEV SENSE

Gait analysis with an Inertial Measurement Unit (IMU) sensor

Gait analysis with reflective markers and pressure sensors

Sponsors

REEV LLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Post-stroke gait disorder. * Must be able to walk independently with or without the support of a cane or rollator. * History of stroke more than six months ago. * Be 18 years of age or older.

Exclusion criteria

* Subject unable to give consent. * Subject unable to understand the tests.

Design outcomes

Primary

MeasureTime frameDescription
Walking speed measure precisionThroughout study completion (an average of 2h)Comparison of walking speed measured with REEV SENSE with reference method

Secondary

MeasureTime frameDescription
Walking cadence measure precision = precision of the number of steps per minuteThroughout study completion (an average of 2h)Comparison of walking cadence measured with REEV SENSE with reference method
Stride length measure precisionThroughout study completion (an average of 2h)Comparison of stride length measured with REEV SENSE with reference method
Swing time measure precisionThroughout study completion (an average of 2h)Comparison of swing time measured with REEV SENSE with reference method
KPP (Knee Position Predictor) measure precision = precision of the predicted angle of knee sagittal flexion in the next 200msThroughout study completion (an average of 2h)Comparison of KPP measured with REEV SENSE with reference method.
Stance symmetry measure precision = precision of the % of unilateral stance time predominance (right or left) compared to total bilateral stance time (right and left)Throughout study completion (an average of 2h)Comparison of stance symmetry measured with REEV SENSE with reference method
Knee flexion angle measure precision in sagittal planThroughout study completion (an average of 2h)Comparison of knee flexion measured with REEV SENSE with reference method
Ankle flexion angle measure precision in sagittal planThroughout study completion (an average of 2h)Comparison of ankle flexion angle measured with REEV SENSE with reference method
Stance time measure precisionThroughout study completion (an average of 2h)Comparison of stance time measured with REEV SENSE with reference method

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026